Literature DB >> 3040177

Endogenous opioids regulate dendritic growth and spine formation in developing rat brain.

K F Hauser, P J McLaughlin, I S Zagon.   

Abstract

Continuous blockade of endogenous opioid-opioid receptor interaction by opioid antagonists from birth to day 10 increased neuronal maturation in the rat brain. The lengths of oblique dendrites of pyramidal cells in the cerebral cortex and basilar dendrites of the hippocampus were increased from controls by 136 and 51%, respectively, whereas the concentrations of spines in these cells were increased 183 and 69%, respectively. Total dendritic length of spiny branches of cerebellar Purkinje neurons was 65% greater than controls, and spine concentration of granule cells in the dentate gyrus was increased by 76%. Thus, endogenous opioids exert a remarkable influence on the timetable and magnitude of dendritic elaboration and spine formation, and serve as an important trophic influence in the regulation of neuro-ontogeny.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3040177     DOI: 10.1016/0006-8993(87)91509-5

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  29 in total

Review 1.  Anesthetic-related neurotoxicity and the developing brain: shall we change practice?

Authors:  Laszlo Vutskits
Journal:  Paediatr Drugs       Date:  2012-02-01       Impact factor: 3.022

Review 2.  Selective vulnerability of cerebellar granule neuroblasts and their progeny to drugs with abuse liability.

Authors:  Kurt F Hauser; Valeriya K Khurdayan; Robin J Goody; Avindra Nath; Alois Saria; James R Pauly
Journal:  Cerebellum       Date:  2003       Impact factor: 3.847

3.  Developmental expression of the mu, kappa, and delta opioid receptor mRNAs in mouse.

Authors:  Y Zhu; M S Hsu; J E Pintar
Journal:  J Neurosci       Date:  1998-04-01       Impact factor: 6.167

4.  Regulation of the expression of the proenkephalin gene in cultured meningeal fibroblasts: opposite effects of alpha 1- and beta 2-adrenoceptors.

Authors:  B Hildebrand; B Wissler; C Olenik; D K Meyer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-10       Impact factor: 3.000

5.  Glial growth is regulated by agonists selective for multiple opioid receptor types in vitro.

Authors:  A Stiene-Martin; K F Hauser
Journal:  J Neurosci Res       Date:  1991-08       Impact factor: 4.164

Review 6.  Developmental consequences of fetal exposure to drugs: what we know and what we still must learn.

Authors:  Emily J Ross; Devon L Graham; Kelli M Money; Gregg D Stanwood
Journal:  Neuropsychopharmacology       Date:  2014-06-18       Impact factor: 7.853

Review 7.  Opioid growth factor and the treatment of human pancreatic cancer: a review.

Authors:  Ian S Zagon; Patricia J McLaughlin
Journal:  World J Gastroenterol       Date:  2014-03-07       Impact factor: 5.742

8.  Glial expression of the proenkephalin gene in slice cultures of the subventricular zone.

Authors:  L Just; C Olenik; D K Meyer
Journal:  J Mol Neurosci       Date:  1998-08       Impact factor: 3.444

9.  Interaction of the mu-opioid receptor with GPR177 (Wntless) inhibits Wnt secretion: potential implications for opioid dependence.

Authors:  Jay Jin; Saranya Kittanakom; Victoria Wong; Beverly A S Reyes; Elisabeth J Van Bockstaele; Igor Stagljar; Wade Berrettini; Robert Levenson
Journal:  BMC Neurosci       Date:  2010-03-09       Impact factor: 3.288

10.  The effects of maternally administered methadone, buprenorphine and naltrexone on offspring: review of human and animal data.

Authors:  W O Farid; S A Dunlop; R J Tait; G K Hulse
Journal:  Curr Neuropharmacol       Date:  2008-06       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.